Greg Guilcher

Gregory Guilcher



Associate Professor

Cumming School of Medicine, Department of Oncology

Associate Professor

Cumming School of Medicine, Department of Pediatrics

Childhood Cancer & Blood Disorders Program Director

Alberta Children's Hospital Research Institute

Child Health & Wellness Researcher

Alberta Children's Hospital Research Institute


Arnie Charbonneau Cancer Institute

Contact information

Phone number

Office- research inquiries only: 403.955.7272

For media enquiries, contact

Kelly Johnston
Senior Communications Specialist

Please submit your media request here


Preferred method of communication

Admin Assistant

Karen Fandrey


Office: 403.955.7272



FRCPC, Royal College of Physicians and Surgeons of Canada, 2005

FAAP, American Academy of Pediatrics, 2004

Educational Background

B.Sc. Biochemistry, Queen's University, 1997

Doctor of Medicine, Memorial University of Newfoundland, 2001

Postgraduate Certificate Medical Education, University of Dundee, 2011

Fellowship Pediatric Hematology/Oncology, University of British Columbia, 2007

Residency Pediatrics, Memorial University of Newfoundland, 2004


Co-Lead of the Alberta Children’s Hospital Hematopoietic Cell Transplant Long-Term Survivor Program, Chair Mentee of the Children’s Oncology Group HCT/Dermatology/Immunology Late Effects Taskforce, Vice Chair of the Board of Directors of the Sickle Transplant Alliance for Research, Vice-Chair of the Royal College Pediatric Hematology/Oncology Examination Committee, Program Director for Pediatric Hematology/Oncology at the University of Calgary.


Areas of Research


Acute and late toxicities of therapy, including pharmacogenomic testing to predict and prevent toxicity. Immune recovery after childhood cancer therapy.

Novel Therapeutics

Dr. Guilcher is a site investigator for several Phase I, II and III studies.


Hematopoietic cell transplantation (HCT) for malignant and non-malignant diseases, with a special interest in sickle cell disease. Chair of the HCT/Immune/Dermatology Late Effects Taskforce for the Children's Oncology Group.

Summary of Research

Research interests include acute and late toxicities of BMT, as well as the study of novel low-toxicity approaches to transplant for pediatric non-malignant diseases. Greg is interested in studying family BMT decision-making , neuropsychological outcomes and health economics questions as related to BMT for sickle cell disease. He also has an interest in pediatric BMT donor safety. A career goal is to expand access to BMT for sickle cell disease to low and middle income countries.


Participation in university strategic initiatives


  • Researcher of the Year, Department of Pediatrics, University of Calgary. 2018
  • President's Excellence Award- Outstanding Achievement in Innovation and Research, Alberta Health Services. 2018